Helicobacter pylori seropositivity and the myeloperoxidase G-463A polymorphism in combination with interleukin-1B C-31T in Japanese health checkup examinees

Japanese Journal of Clinical Oncology

Volumn 33, Issue 4, 2003, Pages 192-197

  Katsuda, Nobuyuki ^a   Hamajima, Nobuyuki ^b   Tamakoshi, Akiko ^b   Wakai, Kenji ^b   Matsuo, Keitaro ^c   Saito, Toshiko ^c   Tajima, Kazuo ^c   Tominaga, Suketami ^c  

^a Nagoya Kita Health Center   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Helicobacter pylori; Interleukin 1B; Myeloperoxidase; Polymorphisms; Smoking

Indexed keywords

INTERLEUKIN 1BETA; MYELOPEROXIDASE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 1; PEROXIDASE;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN PROTEIN INTERACTION; REPRODUCIBILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SMOKING HABIT; STATISTICAL SIGNIFICANCE; BLOOD; GENETIC PREDISPOSITION; GENETICS; HELICOBACTER INFECTION; IMMUNOLOGY; MIDDLE AGED; SEROLOGY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-1; MALE; MIDDLE AGED; PEROXIDASE; POLYMORPHISM, GENETIC; SEROLOGIC TESTS; SMOKING;

EID: 0038808704     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg034     Document Type: Article

References (39)

1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-41.
2. Brown LM. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 2000;22:283-97.
3. Goodman KJ, Correa P. The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol 1995;24:875-87.
4. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-21.
5. Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 1997;25:973-8.
6. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001;107:767-73.
7. Montecucco C, Rappuoli R. Living dangerously: How Helicobacter pylori survives in the human stomach. Nature Rev 2001;2:457-66.
8. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection: Genetic and environmental influence. A study of twins. Ann Intern Med 1994;129:982-6.
9. Go MF. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997;113: S15-S20.
10. Ikehara Y, Nishihara S, Yasutomi H, Kitamura T, Matsuo K, Shimizu N, et al. Polymorphisms of two fucosyltransferase genes (Lewis and secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev 2001;10:971-7.
11. Hamajima N, Matsuo K, Saito T, Tajima K, Okuma K, Yamao K, et al. Interleukin 1 polymorphisms, lifestyle factors and Helicobacter pylori infection. Jpn J Cancer Res 2001;92:383-9.
12. Katsuda N, Hamajima N, Matsuo K, Saito T, Ito LS, Inoue M, et al. Association between the interleukin 1B (C-31T) polymorphism and Helicobacter pylori infection in health checkup examinees. Jpn J Publ Health 2001;48:604-12.
13. Uno M, Hamajima N, Ito LS, Oba SM, Marie SKN, Shinjo SK, et al. Helicobacter pylori seropositivity and IL-1B C-31T polymorphism among Japanese Brazilians. Int J Mol Med 2002;10:321-6.
14. Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Tajima K, et al. Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn J Cancer Res 2001;92:488-93.
15. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001;54:703-6.
16. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-7.
17. Takemura T, Granger DN, Evans DJ Jr, Evans DG, Graham DY, Anderson DC, et al. Extract of Helicobacter pylori induces neutrophils to injure endothelial cells and contains antielastase activity. Gastroenterology 1996;110:21-9.
18. Kim JS, Jung HC, Kim JM, Song IS, Kim CY. Helicobacter pylori water-soluble surface proteins activate human neutrophils and up-regulate expression of CXC chemokines. Dig Dis Sci 2000;45:83-92.
19. Ramarao N, Gray-Owen SD, Meyer TF. Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol Microbiol 2000;38:103-13.
20. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996;271:14412-20.
21. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001;142:336-9.
22. London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997;57:5001-3.
23. Cascorbi I, Henning S, Brockmoller J, Gephart J, Meisel C, Muller JM, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463 of the myeloperoxidase gene. Cancer Res 2000;60: 644-9.
24. Marchand LL, Seifried A, Lum A, Wilkes LR. Association of the myeloperoxidase -463G→A polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:181-4.
25. Matsuo K, Hamajima N, Shinoda M, Hatooka S, Inoue M, Takezaki T, et al. Possible risk reduction in esophageal cancer associated with MPO -463A allele. J Epidemiol 2001;11:109-14.
26. Meisel P, Krause T, Cascorbi I, Schroeder W, Herrmann F, John U, et al. Gender and smoking-related risk reduction of periodontal disease with variant myeloperoxidase alleles. Genes Immun 2002;3:102-6.
27. Crawford FC, Freeman MJ, Schinka JA, Morris MD, Abdullah LI, Richards D, et al. Association between Alzheimer's disease and a functional polymorphism in the myeloperoxidase gene. Exp Neurol 2001;167: 456-9.
28. Nagra RM, Becher B, Tourtellotte WW, Antel JP, Gold D, Paladino T, et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997;78:97-107.
29. Roe I, Nam S, Kim J, Shin J, Bang W, Yang M. Association of the myeloperoxidase -463G→A polymorphism with development of atrophy in Helicobacter pylori-infected gastritis. Am J Gastroenterol 2002;97: 1629-34.
30. Dianarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87: 2095-147.
31. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobactor pylori in gastric cancer. Helicobacter 2001;6:116-24.
32. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998;42:227-34.
33. El-Omar EM, Carrington M, Chow W-H, McColl KEL, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
34. Evans DJ, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989;96:1004-8.
35. Matsuo K, Hamajima N, Tominaga S, Suzuki T, Nakamura T, Matsuura A, et al. Helicobacter pylori IgG antibody test established in the United States showed a substantial lower sensitivity for Japanese population. Am J Gastroenterol 2000;95:1597-8.
36. Hamajima N, Saito I, Matsuo K, Kozaki K, Takahashi T, Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2002;91:865-8.
37. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N. Impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999;67:1828-36.
38. Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Suzuki K, et al. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J Infect Dis 2000;182:1276-9.
39. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter 2001;6:116-24.